Newsletter | May 2, 2024

05.02.24 -- eCOA Solutions In 2024: Trends, Advantages, And Strategic Considerations

FEATURED EDITORIAL

eCOA Solutions In 2024: Trends, Advantages, And Strategic Considerations

The eCOA solution market is anticipated to capture $15.1 billion by the year 2036, growing at a CAGR of almost 15.1% during the forecast period. Learn more by reading this market outlook.

INDUSTRY INSIGHTS

Exploring The Potential Of Non-Consumer Smartphones

We selected and evaluated a non-consumer device, to explore its potential as a reliable tool for home-based ePRO measure administration. Here’s what we learned from this usability testing. 

Automation, Analytics, AI, And The Future Of Trial Monitoring

More teams are utilizing AI and automation to recruit and retain more patients. Discover how predictive analytics allow clinical trial teams to make better prognostications about patient behavior.

Reduce Workloads And Improve Insights With Crowdsource UAT

Learn to expedite UAT through objective evidence exchange, decreased individual workloads for participating sponsors, increased access to users, and faster, more reliable testing.

Data Linkage: Spanning The Clinical To Commercial Gap

Discover the transformative potential of integrating Clinical Trial Data with RWD at the individual patient level, yielding a holistic perspective of the patient journey across all phases.

5 Steps To Overcome Barriers To eRegulatory Adoption

Gain insight from this collection of best practices when transitioning from traditional paper and fragmented technology workflows to a fully electronic and purpose-built eRegulatory platform.